XBiotech (XBIT) Research & Development (2014 - 2026)
XBiotech's Research & Development came in at $5.3 million for Q2 2026, down 0.7% from $5.34 million a year earlier.
Powered by 
Analysis
XBiotech (XBIT) Research & Development (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, XBiotech reported Research & Development of $41.07 million, up 28.7% year-over-year; for FY2025, it came in at $47.39 million, up 25.5% from FY2024.
- Research & Development has increased in each of the last five years, with a five-year compound annual growth rate of 37.8% (FY2020 to FY2025).
- Going back by year, Research & Development was $37.76 million in FY2024 (+14.9%), $32.85 million in FY2023 (+4.1%), $31.54 million in FY2022 (+11.6%) and $28.27 million in FY2021 (+196.7%).
- The five-year range for quarterly Research & Development is $5.08 million (Q3 2025) to $25.36 million (Q4 2025).
- Year-over-year, Research & Development increased in three of the last seven quarters, with growth averaging 21.3%.
- The fastest year-over-year change in Research & Development over five years came in Q4 2025 (growth of 224.2%), and the weakest in Q2 2025 (a decline of 58.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | XBiotech | 65.55 Mn | 65.55 Mn | - | 5.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.30 Mn |
| Dec 31, 2025 | 25.36 Mn |
| Sep 30, 2025 | 5.08 Mn |
| Jun 30, 2025 | 5.34 Mn |
| Mar 31, 2025 | 11.62 Mn |
| Dec 31, 2024 | 7.82 Mn |
| Sep 30, 2024 | 7.13 Mn |
| Jun 30, 2024 | 12.98 Mn |
| Mar 31, 2024 | 9.83 Mn |
| Dec 31, 2023 | 7.80 Mn |
| Sep 30, 2023 | 7.55 Mn |
| Jun 30, 2023 | 11.27 Mn |
| Mar 31, 2023 | 6.23 Mn |
| Dec 31, 2022 | 7.32 Mn |
| Sep 30, 2022 | 7.01 Mn |
| Jun 30, 2022 | 10.39 Mn |
| Mar 31, 2022 | 6.82 Mn |
| Dec 31, 2021 | 8.78 Mn |
| Sep 30, 2021 | 5.60 Mn |
| Jun 30, 2021 | 9.25 Mn |
API Access
XBiotech Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=XBIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "XBIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=XBIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();